HARRIGAN EDMUND 1177917 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-19 | 2023-05-19 | 4 | Harrigan Edmund | DIRECTOR | acq | 3750.0 | 38.46 | 0.75 | 0.0 | Direct | Common Stock | PHASEBIO PHARMACEUTICALS INC | code M | 9750.0 | 49.86 (PHAS) |
| 2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Harrigan Edmund | DIRECTOR | acq | 18002.0 | 94.74 | 1.11 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 19002.0
|
162.63 (ACAD) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Harrigan Edmund | DIRECTOR | acq | 2505.0 | 21.78 | 0.11 | 0.0 | Direct | Common Stock | INCYTE CORP | code A | 11500.0 | 223.09 (INCY) |
| 2023-07-05 | 2023-06-30 | 2023-06-30 | 4 | Harrigan Edmund | DIRECTOR | acq | 390.0 | 3.28 | 0.02 | 62.25 | Direct | Common Stock | INCYTE CORP | code A | 11890.0 | 223.09 (INCY) |
| 2023-10-03 | 2023-09-29 | 2023-09-29 | 4 | Harrigan Edmund | DIRECTOR | acq | 389.0 | 3.17 | 0.02 | 57.77 | Direct | Common Stock | INCYTE CORP | code A | 12279.0 | 224.09 (INCY) |
| 2024-01-03 | 2023-12-29 | 2023-12-29 | 4 | Harrigan Edmund | DIRECTOR | acq | 423.0 | 3.33 | 0.02 | 62.79 | Direct | Common Stock | INCYTE CORP | code A | 12702.0 | 224.11 (INCY) |
| 2024-04-02 | 2024-03-28 | 2024-03-28 | 4 | Harrigan Edmund | DIRECTOR | acq | 413.0 | 3.15 | 0.02 | 56.97 | Direct | Common Stock | INCYTE CORP | code A | 13115.0 | 224.53 (INCY) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-19 | 2023-05-19 | 4 | Harrigan Edmund | DIRECTOR | acq | 3750.0 | 0 | 0.75 | 0.0 | Direct | Restricted Stock Units | PHASEBIO PHARMACEUTICALS INC | code M | 0.0 | 49.86 (PHAS) |
| 2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Harrigan Edmund | DIRECTOR | acq | 11045.0 | 100.0 | 0.68 | 23.9 | Direct | Director Stock Options (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 11045.0 | 162.63 (ACAD) |
| 2023-06-05 | 2021-06-22 | 2021-06-22 to 2023-06-01 | 4 | Harrigan Edmund | DIRECTOR | dsp | 18002.0 | 100.0 | 1.11 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 0.0
|
162.63 (ACAD) |
| 2023-06-05 | 2021-06-22 | 2023-06-01 | 4 | Harrigan Edmund | DIRECTOR | acq | 6652.0 | 100.0 | 0.41 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code A | 6652.0 | 162.63 (ACAD) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Harrigan Edmund | DIRECTOR | acq | 11294.0 | 100.0 | 0.51 | 61.44 | Direct | Non Qualified Stock Option (Right To Buy) | INCYTE CORP | code A | 11294.0 | 223.09 (INCY) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)